Teleflex Incorporated (TFX)

NYSE
Currency in USD
129.29
+2.80(+2.21%)
Closed·
After Hours
129.290.00(0.00%)
·
TFX Scorecard
Full Analysis
Management has been aggressively buying back shares
TFX is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
125.92129.29
52 wk Range
120.06249.91
Key Statistics
Edit
Prev. Close
126.49
Open
127.53
Day's Range
125.92-129.29
52 wk Range
120.06-249.91
Volume
505.22K
Average Vol. (3m)
1.19M
1-Year Change
-42.45%
Book Value / Share
91.65
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
TFX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
155.82
Upside
+20.52%
Members' Sentiments
Bearish
Bullish
ProTips
High shareholder yield
Show more

Teleflex Incorporated Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous bone access systems for the administration of intravenous therapies, the measurement of blood pressure, and the collection of blood samples. The company also offers interventional products, including various coronary catheters, structural heart support devices, peripheral intervention products, and mechanical circulatory support platform; and Arrow branded intra-aortic balloon pumps and catheters, Guideliner, Turnpike, and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. It provides anesthesia products, such as airway, pain management, and hemostatic products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligating clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. The company also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms; respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings; urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology, as well as bladder management services; and OEM products, which includes the TFX Medical OEM, TFX OEM, Deknatel, and HPC Medical brands. It serves hospitals and healthcare providers, medical device manufacturers, and home care markets. Teleflex Incorporated was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.

Teleflex Incorporated SWOT Analysis


Analyst Outlook
Price targets range from $210 to $285, reflecting varied optimism about Teleflex's future prospects and ability to overcome current headwinds
Strategic Vision
Delve into Teleflex's growth strategy, combining organic expansion with strategic acquisitions to strengthen market position and drive innovation
Market Dynamics
Explore Teleflex's navigation of complex market forces, from unexpected customer losses to promising growth in key segments like Intra-Aortic Balloon Pumps
Financial Resilience
Teleflex demonstrates adaptability amidst challenges, adjusting guidance while maintaining profitability through effective cost management and strategic initiatives
Read full SWOT analysis

Teleflex Incorporated Earnings Call Summary for Q1/2025

  • Teleflex Q1 2025 EPS of $2.91 missed $2.95 forecast; revenue of $700.7M fell short of $705.99M estimate, leading to 2.23% stock dip
  • Company plans to separate into two publicly traded entities, completed $300M share repurchase, and explores tariff mitigation strategies
  • Revenue down 5% YoY; adjusted constant currency revenue decreased 3.8%; adjusted EPS dropped 9.3% from prior year
  • 2025 guidance: 1-2% adjusted constant currency revenue growth, adjusted EPS $13.2-$13.6; expects sequential improvement in China business
  • Challenges include $55M tariff impact, market saturation in UroLift and OEM segments, and ongoing supply chain disruptions
Last Updated: 05/01/2025, 09:12 AM
Read Full Transcript

Compare TFX to Peers and Sector

Metrics to compare
TFX
Peers
Sector
Relationship
P/E Ratio
38.2x35.1x−0.5x
PEG Ratio
−0.780.150.00
Price / Book
1.4x4.1x2.6x
Price / LTM Sales
1.9x7.0x2.9x
Upside (Analyst Target)
12.9%19.8%45.8%
Fair Value Upside
Unlock−15.3%8.6%Unlock

Analyst Ratings

2 Buy
11 Hold
1 Sell
Ratings:
14 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 155.82
(+20.52% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 3.21%
Dividend Yield
1.08%
Industry Median 0.71%
Annualized Payout
1.36
Paid quarterly
5-Years Growth
-
Growth Streak

Earnings

Latest Release
May 01, 2025
EPS / Forecast
2.91 / 2.88
Revenue / Forecast
700.70M / 699.00M
EPS Revisions
Last 90 days

People Also Watch

49.15
TECH
+1.89%
24.63
YOU
-0.04%
305.74
MEDP
+3.15%
8.195
AUPH
+0.55%

FAQ

What Is the Teleflex (TFX) Stock Price Today?

The Teleflex stock price today is 129.29

What Stock Exchange Does Teleflex Trade On?

Teleflex is listed and trades on the New York Stock Exchange stock exchange.

What Is the Stock Symbol for Teleflex?

The stock symbol for Teleflex is "TFX."

Does Teleflex Pay Dividends? What’s The Current Dividend Yield?

The Teleflex dividend yield is 1.08%.

What Is the Teleflex Market Cap?

As of today, Teleflex market cap is 5.68B.

What Is Teleflex's Earnings Per Share (TTM)?

The Teleflex EPS (TTM) is 3.21.

When Is the Next Teleflex Earnings Date?

Teleflex will release its next earnings report on Jul 24, 2025.

From a Technical Analysis Perspective, Is TFX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.